Dresher, PA, United States of America

Raghava Potula

This inventor holds 1 USPTO granted patent. Top assignee: Temple University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raghava Potula. Retrieved from https://idiyas.com/inventor/raghava-potula-bc9tjqvi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raghava Potula: Innovator in MAP Antibody Testing

Introduction

Raghava Potula is a notable inventor based in Dresher, PA (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection and diagnosis of MAP-associated diseases. His innovative work has the potential to improve the lives of many individuals suffering from autoimmune disorders.

Latest Patents

Raghava Potula holds a patent for "Combinatorial MAP antibody tests for detection and diagnosis." This patent provides kits for detecting subspecies paratuberculosis (MAP) infection and biomarkers correlated with MAP-associated diseases or disorders. The disclosure also includes methods for diagnosing subjects with MAP-associated autoimmune diseases and determining appropriate treatment courses.

Career Highlights

Raghava Potula is affiliated with Temple University, where he continues to advance research in the field of immunology and diagnostics. His work is characterized by a commitment to developing innovative solutions that address critical health challenges.

Collaborations

Raghava Potula collaborates with John Todd Kuenstner, enhancing the research efforts at Temple University. Their combined expertise contributes to the advancement of diagnostic methodologies in the medical field.

Conclusion

Raghava Potula's contributions to the field of MAP antibody testing exemplify the impact of innovation in medical diagnostics. His work not only furthers scientific understanding but also holds promise for improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…